Connect with Us at the Upcoming Events

With in-person events back again, Creative Biolabs is excited to greet you at the upcoming international conferences. Meet our team at 2022 BIO International Convention in June (booth #1754) and at the 13th Annual World ADC San Diego in September (booth number to be updated) for expert consultation on your drug discovery. Shoot an email to arrange an in-person meeting!

Book a Meeting

CytoTox™ Complement System Classical Pathway Assay Kit (CAT#: CB-P209-K) Datasheet

Product Type
Kit
Description
The CytoTox™ Complement System Classical Pathway is an immunoassay for the qualitative and/or semi-quantitative assay of functional classical complement pathway and assay of complement deficiencies in human serum.

The CytoTox™ Complement Classical Pathway assay combines the specific activation of the pathway with the use of labeled antibodies specific for a neoepitope of the terminal complement complex, C5b-9, produced as the result of complement activation. Objective quantification of the activity of the classical pathway is valuable in a number of different clinical situations. The amount of complement activation can be expressed either in a qualitative way relative the value of a positive control or in a semi-quantitative way using a calibrator curve derived from a separate lyophilized activity control.
Size
96 wells

Figure 1 CP Qualitative application.

Table 1.

Table 2 Sera with known complement deficiencies were tested in the assay and the following results were obtained.


Table 3. Inter-assay precision was determined by testing three samples in duplicate. Results were obtained for six different runs.

Table 4. Intra-assay precision for qualitative application was determined by testing one sample in 40 wells.

All products and services are for Research Use Only. Do Not use in humans.

ONLINE INQUIRY

Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *
  • *
USA

UK